Regular ArticlePharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab - preclinical and clinical studies
Keywords: AA; arachidonic acid; ADP; adenosine diphosphate; ACS; acute coronary syndrome; APC; allophycocyanin; CAD; coronary artery disease; FITC; fluorescein isothiocyanate; huIgG4; human immunoglobulin G4; HuMab; human monoclonal antibody; HV; healthy volunteers